CBE Research Day - Photoresponsive Nanomedicine for the Treatment of Cancer and Eye Diseases
Supporting the below United Nations Sustainable Development Goals:支持以下聯合國可持續發展目標：支持以下联合国可持续发展目标：
Photoresponsive drug delivery strategy can enhance the accumulation of therapeutic agents at targeted sites where light is applied, thereby maximizing therapeutic efficacy while minimizing side effects. Currently, this strategy faces challenges in clinical applications, such as limited light penetration depth in biological tissues. In this talk, I will present our research on the development of simple photoresponsive drug delivery systems for the treatment of cancer and eye diseases. Moreover, I will discuss the approaches we have developed to overcome the challenge of limited light penetration within the body. By exploring these advancements and solutions, we aim to further the potential of photoresponsive nanomedicine in treating a wide range of diseases through interdisciplinary collaborations.
Dr. Weiping Wang is an Associate Professor at Department of Pharmacology and Pharmacy & Dr. Li Dak-Sum Research Centre, The University of Hong Kong (HKU). He is also a Principal Investigator at the State Key Laboratory of Pharmaceutical Biotechnology at HKU. He obtained his PhD from The Hong Kong University of Science and Technology (HKUST). He conducted postdoctoral research at Massachusetts Institute of Technology and Harvard Medical School. Dr. Wang has received multiple honours and awards, including 2011 Air Products Best Postgraduate Award for Research Excellence from HKUST Department of Chemical and Biomolecular Engineering, 2011 PhD Research Excellence Award from HKUST School of Engineering, 2018 Nano Research Young Innovator Award in Nanobiotechnology, 2022 NSFC Excellent Young Scientists Fund, and three Gold Medals from 2022 & 2024 International Exhibition of Inventions Geneva. His current research interests include photopharmacology, nanomedicine, ocular drug delivery, and stimuli-triggered drug delivery. Dr. Wang is an Associate Editor for Medicinal Research Reviews.